These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39077969)

  • 1. Pain is a cardinal symptom cutting across Rome IV anatomical categories in disorders of gut-brain interaction: A network-based approach.
    Burton-Murray H; Guadagnoli L; Vanzhula IA; Brown TA; Sperber AD; Palsson O; Bangdiwala SI; Van Oudenhove L; Staller K
    Neurogastroenterol Motil; 2024 Oct; 36(10):e14877. PubMed ID: 39077969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
    Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study.
    Flores-Arriaga J; Aso MC; Izagirre A; Sperber AD; Palsson OS; Bangdiwala SI; Lanas Á; Bujanda L; Lobo B; Alonso-Cotoner C; Sánchez-Pla Á; Santos J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14582. PubMed ID: 37010843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of disorders of Gut-Brain interaction in Israel: Results from the Rome Foundation global epidemiology study.
    Sperber AD; Freud T; Abu-Freha N; Shibli F; Brun R; Bangdiwala SI; Palsson OS; Dickman R
    Neurogastroenterol Motil; 2022 Aug; 34(8):e14323. PubMed ID: 35072332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology and impact of disorders of gut-brain interaction in Canada: Results from the Rome Foundation Global Epidemiologic Study.
    Rodrigues DM; Poitras P; Day AG; Sperber AD; Palsson O; Bangdiwala SI; Vanner SJ
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14585. PubMed ID: 36989173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Disorders of the Gut-Brain Interaction: An Appraisal of the Rome IV Criteria and Beyond.
    Ray G; Ghoshal UC
    Gut Liver; 2024 Jul; 18(4):578-592. PubMed ID: 38680110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology and psychological comorbidity of disorders of gut-brain interaction in Australia: Results from the Rome Foundation Global Epidemiology Study.
    Knowles SR; Apputhurai P; Palsson OS; Bangdiwala S; Sperber AD; Mikocka-Walus A
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14594. PubMed ID: 37052411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study.
    Fukudo S; Nakaya K; Muratsubaki T; Nakaya N; Hozawa A; Bangdiwala SI; Palsson OS; Sperber AD; Kanazawa M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14581. PubMed ID: 37093785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups.
    Hreinsson JP; Törnblom H; Tack J; Drossman DA; Whitehead WE; Bangdiwala SI; Sperber AD; Palsson OS; Simrén M
    Gastroenterology; 2023 Jun; 164(7):1211-1222. PubMed ID: 36889555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of disorders of gut-brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study.
    Hreinsson JP; Wong RKM; Tack J; Whorwell P; Benninga MA; Andresen V; Bonaz B; Choi SC; Corazziari ES; Santos J; Fukudo S; Kanazawa M; Fang X; Bangdiwala SI; Sperber AD; Palsson OS; Simrén M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14566. PubMed ID: 36961016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education.
    Simons J; Shajee U; Palsson O; Simren M; Sperber AD; Törnblom H; Whitehead W; Aziz I
    United European Gastroenterol J; 2022 Sep; 10(7):736-744. PubMed ID: 35781806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Work productivity and activity impairment in disorders of gut-brain interaction: Data from the Rome Foundation Global Epidemiology Study.
    Frändemark Å; Törnblom H; Hreinsson JP; Andresen V; Benninga MA; Corazziari ES; Fukudo S; Mulak A; Santos J; Sperber AD; Bangdiwala SI; Palsson OS; Simrén M
    United European Gastroenterol J; 2023 Jul; 11(6):503-513. PubMed ID: 37332146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the epidemiology of disorders of gut-brain interaction in four Latin American countries: Results of The Rome Foundation Global Epidemiology Study.
    Schmulson MJ; Puentes-Leal GA; Bustos-Fernández L; Francisconi C; Hani A; López-Colombo A; Palsson OS; Bangdiwala SI; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14569. PubMed ID: 36989176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global prevalence and burden of meal-related abdominal pain.
    Colomier E; Melchior C; Algera JP; Hreinsson JP; Störsrud S; Törnblom H; Van Oudenhove L; Palsson OS; Bangdiwala SI; Sperber AD; Tack J; Simrén M
    BMC Med; 2022 Feb; 20(1):71. PubMed ID: 35172840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aging gut: Symptoms compatible with disorders of gut-brain interaction (DGBI) in older adults in the general population.
    Busby-Whitehead J; Whitehead WE; Sperber AD; Palsson OS; Simrén M
    J Am Geriatr Soc; 2024 Feb; 72(2):479-489. PubMed ID: 37945291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aging gastrointestinal tract: Epidemiology and clinical significance of disorders of gut-brain interaction in the older general population.
    Sperber AD; Freud T; Palsson OS; Bangdiwala SI; Simren M
    Aliment Pharmacol Ther; 2024 Aug; 60(4):446-456. PubMed ID: 38837277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Burden of Disorders of Gut-Brain Interaction in Romania: A Subgroup Analysis of the Rome Foundation Global Epidemiology Study.
    Dumitrascu DL; Freud T; Ismaiel A; Bangdiwala SI; Palsson OS; Sperber AD
    J Gastrointestin Liver Dis; 2022 Sep; 31(3):273-282. PubMed ID: 36004415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of disorders of gut-brain interaction in Belgium and differences between two language groups: Results from the Rome foundation global epidemiology study.
    Broeders B; Devolder E; Jones M; Simrén M; Bangdiwala SI; Sperber AD; Palsson OS; Tack J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14588. PubMed ID: 37018388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative Impact of Disorders of Gut-Brain Interaction on Health-Related Quality of Life: Results From the Rome Foundation Global Epidemiology Survey.
    Knowles SR; Skvarc D; Ford AC; Palsson OS; Bangdiwala SI; Sperber AD; Mikocka-Walus A
    Gastroenterology; 2023 Apr; 164(4):655-668.e10. PubMed ID: 36565940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.